Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1Endocrine 1CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Wilms Tumor 1Sarcoma, Ewing 1Rhabdomyosarcoma, Alveolar 1Rhabdomyosarcoma 1Retinoblastoma 1Neuroblastoma 1Melanoma 1Medulloblastoma 1Glioblastoma 1Carcinoid Tumor 1

Interventions

Carboplatin 26Etoposide 22Vincristine 18Melphalan 14Filgrastim 14Topotecan 11Granulocyte Colony-Stimulating Factor 10Cyclophosphamide 9Thiotepa 7Cryotherapy 6Peripheral Blood Stem Cell Transplantation 4Mesna 4Drug Therapy 4Busulfan 4Radiotherapy 3Ifosfamide 3Doxorubicin 3Temozolomide 2Platinum Compounds 2Eye Enucleation 2Cisplatin 2Brachytherapy 2trioctyl phosphine oxide 1sargramostim 1racotumomab 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1etoposide phosphate 1cixutumumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Retinoblastoma × Biological Factors × Clear all
NCT00314925 2010-02-25

Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features

Neotropix

Phase 1 Unknown
60 enrolled
CNSEndocrineGenitourinaryOther solid neoplasmSarcoma

Carcinoid Tumor, Glioblastoma, Medulloblastoma, Wilms Tumor, Neuroblastoma, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Rhabdomyosarcoma, Alveolar

Data powered by HemOnc (CC BY 4.0) Colophon âš¡